Česky English

+420 511 181 555

info@iccti.eu

For members

ICCTI membership
Starting from January 2015 ICCTI is formally registered as a Scientific Society. To become an ICCTI member is very simple. Just fill in the enclosed FORM and select the type of your membership. By sending ICCTI Membership Application Form you agree with ICCTI Bylaws. The list of recent ICCTI members is shown bellow. Please, apply for ICCTI membership by April 30 of the calendar year to qualify for ICCTI Annual Conference reduced fee.

ICCTI Membership fees
Once we receive your ICCTI Membership Application Form you will receive an e-mail with payment details within 14 days.


List of ICCTI members:

  • L. Adamson, MD Cancer Centre, Karolinska Institutet, Stockholm, Sweden
  • N. Aghdami, MD Royan Institute, Teheran, Iran
  • R. W. Alexander, MD, FICS University of Washington, Seattle, Washington, USA
  • C. Altaner, Assoc. Prof., PhD, DrSc. Cancer Research Institute SAS, Bratislava, Slovakia
  • J. Barrett, MD, PhD National Institutes of Health, Hematology Branch, Bethesda, Maryland, USA
  • A. Berrebi, MD Hematology Institute, Kaplan Medical Center, Rehovot, Izrael
  • C. M. Bollard, MD Baylor College of Medicine, Center for Cell and Gene Therapy, Houston, Texas, USA
  • F.M. Brehar, MD, PhD First Neurosurgery Department, Emergency Clinical Hospital, Bukurest, Romania
  • M. Bright Macquarie Stem Cells, London, Great Britain
  • R. Bright, MD Macquarie Cosmetic Medicine, Liverpool NWSW, Australia
  • P. Budzák Fitliner s.r.o., Slovakia
  • G. M. Butenko, PhD Department of Cellular and Tissues Technologies, Institute of Genetic and Regenerative Medicine, Academy of Science, Ukraine
  • E. Chernykh, MD, PhD Research Institute for Clinical Immunology, Russian Academy of Medical Sciences, Siberian Branch, Novosibirsk, Russia
  • A. Darinskas, PhD Lithuania Health Science University, Kaunas, Lithuania
  • M. Dominici, MD Head Laboratory of Cell Biology and Advanced Cancer Therapies, Dpt. Oncology, Hematology and Respiratory Diseases, University Hospital of Modena and Reggio Emilia, Modena, Italy
  • M. Edinger, MD, PhD University Hospital Regensburg, Regensburg, Germany
  • V. Ehemann, MD, PhD Pathologisches Institut, Universitat Heidelberg, Heidelberg, Germany
  • H. Einsele, MD, PhD Department of Hematology, University of Wuerzburg, Wuerzburg, Germany
  • A. Facciabene, PhD Ovarian Cancer Research Center, School of Medicine, University of Pennsylvania, Pennsylvania, USA
  • T. Felzmann, MD, PhD Children´s Cancer Research Institute, Vídeň, Rakousko
  • M. Flower CaridianBCT, Lakewood, Colorado, USA
  • M. Foti, PhD Department of Biotechnology and Bioscience, Universita Degli Studi di Milano-Bicocca, Milano, Italy
  • Ch. Gabriel, MD Rotes Kreuz Landesverband Oberösterreich, Blutzentrale Linz – Austrian Cluster for Tissue Regeneration, Austria
  • D. Garcia-Olmo, Prof. Fundacion Jimenez Diaz University Hospital, Madrid, Spain
  • K. Giannopoulos, MD, PhD Medical University at Lublin, Lublin, Poland
  • Y. Godfrin, PhD ERYTECH Pharma, Lyon, France
  • M.J. Gonzalez-Guzman, Prof. MD School of Public Health in the Medical Sciences Campus, University of Puerto Rico, Ponce, Puerto Rico
  • E.A.J.M. Goulmy, MD, PhD Department of Immunohematology and Blood Transfusion, Leiden, Netherland
  • B. Guinn, Dr, Division of Science, University of Bedfordshire, Luton, Great Britain
  • D.J. Hammond, MD The International Stem Cell Society STEMSO, Anderson, South Carolina, USA
  • D. Hart, MB DPhil Dendritic Cell Biology and Therapeutics, University of Sydney, Sydney, Australia
  • F. Hildner, MD Red Cross Blood Transfusion Service of Upper Austria, Linec, Austria
  • M. Imhof, PhD Life Research Technologies, Vienna, Austria
  • N. Karandikar, MD, PhD Department of Pathology and Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
  • A. Keating, MD, PhD Department of Cell Therapy, University of Toronto, Toronto, Canada
  • V.A. Kozlov, MD, PhD Research Institute for Clinical Immunology, Russian Academy of Medical Sciences, Siberian Branch, Novosibirsk, Russia
  • B.J. Kroesen, PhD Dept. Pathology and Medical Biology University Medical Center Groningen, Groningen, Netherland
  • L. Kucerova, PhD Cancer Research Institute SAS, Bratislava, Slovakia
  • P. Kudela, PhD BIRD-C Gmbh&CoKG, The Bacterial Ghost Company, Vienna, Austria
  • G. Kvalheim, MD, PhD Department of Cellular Therapy, Radiumhospitalet, Oslo University, Oslo, Norway
  • C. Leclerc, PhD Head of Unit Biologie des Regulations Immunitaires, Institut Pasteur, Paris, France
  • E. Lombardo, PhD TiGenix – Marconi 1, Madrid, Spain
  • T.K. Malan, MD Innovative Cosmetic Surgery Center, Scottsdale, Arizona, USA
  • L.Martinez, MD, MPH Xyrion medical, Ponce, Dominican republic
  • I. Matthiesen, PhD HumanMed AG, Schwerin, Germany
  • R.W. Mays, PhD Regenerative Medicine, Athersys Inc, Cleveland, Ohio, USA
  • K.H.G. Mills, PhD School of Biochemistry and Immunology, Trinity College, Dublin, Ireland
  • V. Pekařík, PhD Cellular and Molecular Neurobiology, CEITEC, Masaryk University, Brno, Czech republic
  • J. Pinxteren, PhD Regenesys, Belgium
  • D. Powell, PhD University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • K. Proefrock, MD AZ Stem Cell Center/American Naturopathic Research Institute, Sun City, Arizona, USA
  • I. Puzanov, MD PhD Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA
  • M. Raška, MD PhD Ustav imunologie, Lékařská fakulta, Univerzita Palackého, Olomouc, Czech republic
  • H. Redl, PhD Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austrian Cluster for Tissue Regeneration, Vienna, Austria
  • K. Rezvani, MD, PhD Imperial College, Hematology Departent, Hammersmith Hospital, London, Great Britain
  • J. Rosocha, MD, PhD Univerzita P.J.Šafárika, Košice, Slovakia
  • S. Rossi, PhD Cell Therapy, CaridianBCT, Denver, Colorado, USA
  • G. Safrany, MD, PhD Department of Molecular and Tumor Radiobiology, National Research Institute, Budapest, Hungary
  • V.E.J.C. Schijns, PhD Cell Biology and Immunology Group, Wageningen University, Wageningen, Netherland
  • M. Schmitt, MD, PhD Department of Internal Medicine, Universitat Rostock, Rostock, Germany
  • S. Slavin, MD, PhD International Center for Cell Therapy and Cancer Immunotherapy Weizman Center, Tel Aviv, Israel
  • E. Smits, PhD Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital and Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, University of Antwerp, Antverpy, Belgium
  • R. Sorg, PhD Department of Immunotherapy, Heinrich Heine University Hospital, Duesseldorf, Germany
  • F.K. Stevenson, PhD University of Southampton, Souhtampton, Great Britain
  • M. Strioga, PhD Laboratory of Immunology, Institute of Oncology, Vilnius University, Vilnius, Lithuania
  • D. Štěpán, MD Plastic Surgery Brno, Czech republic
  • V. van Tendeloo, PhD Center for Cellular Therapy and Regenerative Medicine, University of Antverp, Antverpy, Belgium
  • U. Toh, MD Kurume University School of Medicine, Fukuoka, Japan
  • C. Tremolada, Prof. MD Lipogems International Srl, Milano, Italy
  • K. Ueberreiter, Prof. MD Park-Klinik Birkenwerder, Berlin, Germany
  • E. Yakushenko Research Institute of Clinical Immunology SB RAMS, Novosibirsk, Russia
  • D. Zheng, PhD Chinese Academy of Medical Sciences, Peking, China
  • M.B. Zocca, MSc PhD DanDrit Biotech, Copenhagen, Denmark

© 2017 ICCTI. Mezinárodní konsorcium pro buněčnou terapii a imunoterapii | registrační číslo projektu: CZ.1.07/2.3.00/20.0012